samedan logo
 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

New Control Valve for Low Flowrates

GEMÜ

GEMÜ has developed the new GEMÜ 565 pneumatic control valve for low flowrates in dosing applications.

Standard versions are available in DN 3 - 15 with Kv values from 63 - 3,300 l/h. The control characteristics are linear or equal-percentage depending on the regulating cone. Subsequent replacement of the regulating cone is possible at any time.

A particular advantage is the hermetic separation between actuator and working medium by a sealing diaphragm which is available in EPDM or FPM and can easily be replaced. The valve body can be chosen as either PVDF, PVC-U or stainless steel 1.4435 making the valve suitable for use in the pharmaceutical industry as well as in chemical, electroplating, water treatment and other demanding industrial chemical applications. The maximum operating temperature is 60-80°C dependent on the valve body and has a permissible maximum operating pressure between 0-6 bar dependent on version and operating temperature.

The valve can be paired with all electro-pneumatic GEMÜ valve positioners. Using the GEMÜ 1434 positioner a very compact and low cost version can be provided. The GEMÜ 1435 and 1436 positioners are adapted via a travel sensor. When combined with the 1436 process controller, a PID control system can be implemented. This new valve has a considerably shorter response and control time compared to earlier motorised valves.

+49 794 012 3467
info@gemue.de
www.gemue.de
GEMÜ Gebr. Müller Apparatebau GmbH & Co. KG, Fritz-Müller-Strasse 6-8, D-74653 Ingelfingen
 
Print this page
Send to a friend
   
spacer

News and Press Releases

TB Alliance and BioFocus sign compound management agreement

BioFocus recently announced that it has signed a three year compound management agreement with the Global Alliance for TB Drug Development (TB Alliance). Under this agreement BioFocus will manage TB Alliance’s chemical library collection. These services will be provided by BioFocus’ compound management facility in South San Francisco, USA.
More info >>

Industry Events

C21 BioVentures

25-27 May 2010, California, US

C21 BioVentures™(C21) is the leading conference where early stage innovators, investors and pharma partners come together to do the deals that will make 2010 the year of global partnering. C21 features private company presentations, pre-scheduled face-to-face partnering meetings, expert panels, workshops and three days of networking opportunities at an intimate world-class resort and spa.
More info >>

 
©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement